Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Real-time Estimate Cboe BZX
Other stock markets
 18:28:46 17/05/2024 BST 		5-day change 1st Jan Change
0.634 USD +0.63% Intraday chart for Galecto, Inc. -7.27% -12.44%
05-01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI
04-29 Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GALECTO, INC. Stock Galecto, Inc.
 17.08M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
BIONTECH SE Stock BioNTech SE
 22.41B -
ARGENX SE Stock argenx SE
 22.28B -
GENMAB A/S Stock Genmab A/S
 19.07B
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. Sector Chart